ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

57
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
bearishHugel Inc
29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
477 Views
Share
28 Mar 2019 21:42

Smartkarma’s Week That Was in JP/​​​​​​​​KR: Semiconductor Warnings, Exit of Chairman Cho, & 청년수당

In the past week, there were earnings warnings from three major players in the global semiconductor sector, including Samsung Electronics (005930...

Logo
716 Views
Share
28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
439 Views
Share
17 Jan 2018 15:06

KRX 300 - Selection Process Summary & Current Mood

Feb 5 is our big day. On Feb 5 the KRX will announce more details about this highly anticipated and much awaited new KOSPI+KOSDAQ integrated...

Logo
655 Views
Share
x